肝移植受者接种第二剂BNT162b2 mRNA新冠疫苗后的抗体反应 - Suppr

Suppr

超能文献

Antibody Response After a Second Dose of the BNT162b2 mRNA COVID-19 Vaccine in Liver Transplant Recipients.

作者信息

Sakai Akiyoshi, Morishita Tetsuji, Matsunami Hidetoshi

机构信息

Department of Clinical Laboratory, Matsunami General Hospital, Gifu, Japan.

Department of Internal Medicine, Matsunami General Hospital, Gifu, Japan.

出版信息

Transpl Int. 2022 Mar 16;35:10321. doi: 10.3389/ti.2022.10321. eCollection 2022.

DOI:10.3389/ti.2022.10321

PMID:35368643

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8964939/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c386/8964939/0fbf485f09ca/ti-35-10321-g001.jpg

相似文献

Antibody Response After a Second Dose of the BNT162b2 mRNA COVID-19 Vaccine in Liver Transplant Recipients.肝移植受者接种第二剂BNT162b2 mRNA新冠疫苗后的抗体反应

Transpl Int. 2022 Mar 16;35:10321. doi: 10.3389/ti.2022.10321. eCollection 2022.

Seroconversions After Withdrawal From Mycophenolate Mofetil in Solid Organ Transplant Recipients Without a Third Dose of BNT162b2 mRNA Coronavirus Disease 2019 Vaccine: A Case Series.实体器官移植受者停用吗替麦考酚酯后在未接种第三剂BNT162b2 mRNA新型冠状病毒肺炎疫苗情况下的血清学转换：病例系列

Transplantation. 2022 Apr 1;106(4):e238-e239. doi: 10.1097/TP.0000000000004043.

Poor Antibody Response After Two Doses of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine in Transplant Recipients.移植受者接种两剂严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）疫苗后的抗体反应不佳。

Clin Infect Dis. 2022 Mar 23;74(6):1093-1096. doi: 10.1093/cid/ciab580.

Differences in Antibody Responses Between an Inactivated SARS-CoV-2 Vaccine and the BNT162b2 mRNA Vaccine in Solid-Organ Transplant Recipients.实体器官移植受者中灭活 SARS-CoV-2 疫苗和 BNT162b2 mRNA 疫苗的抗体反应差异。

Exp Clin Transplant. 2021 Dec;19(12):1334-1340. doi: 10.6002/ect.2021.0402.

Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort study.肾移植受者对 SARS-CoV-2 mRNA 疫苗的抗体反应：一项前瞻性队列研究。

Clin Microbiol Infect. 2021 Aug;27(8):1173.e1-1173.e4. doi: 10.1016/j.cmi.2021.04.028. Epub 2021 May 3.

Seroprevalence of SARS-CoV-2 spike IgG antibodies after the second BNT162b2 mRNA vaccine in Japanese kidney transplant recipients.日本肾移植受者接种第二剂 BNT162b2 mRNA 疫苗后对 SARS-CoV-2 刺突 IgG 抗体的血清阳性率。

Sci Rep. 2022 Apr 7;12(1):5876. doi: 10.1038/s41598-022-09897-0.

Germline variants of IGHV3-53 / V3-66 are determinants of antibody responses to the BNT162b2 mRNA COVID-19 vaccine.IGHV3-53 / V3-66的种系变体是对BNT162b2 mRNA新冠疫苗抗体反应的决定因素。

J Infect. 2022 Dec;85(6):702-769. doi: 10.1016/j.jinf.2022.10.015. Epub 2022 Nov 2.

Dynamics of Antibody Response to BNT162b2 mRNA COVID-19 Vaccine: A 7-Month Follow-Up Study.BNT162b2 mRNA COVID-19 疫苗的抗体反应动力学：7 个月随访研究。

Medicina (Kaunas). 2021 Dec 5;57(12):1330. doi: 10.3390/medicina57121330.

Differences in IgG Antibody Responses following BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines.BNT162b2 和 mRNA-1273 两种 SARS-CoV-2 疫苗接种后的 IgG 抗体反应差异。

Microbiol Spectr. 2021 Dec 22;9(3):e0116221. doi: 10.1128/Spectrum.01162-21. Epub 2021 Nov 10.

Dynamics of antibody response to BNT162b2 mRNA COVID-19 vaccine after 6 months.6个月后对BNT162b2 mRNA新冠疫苗抗体反应的动态变化

J Travel Med. 2021 Dec 29;28(8). doi: 10.1093/jtm/taab173.

引用本文的文献

Factors influencing immunogenicity and safety of SARS-CoV-2 vaccine in liver transplantation recipients: a systematic review and meta-analysis.影响肝移植受者 SARS-CoV-2 疫苗免疫原性和安全性的因素：系统评价和荟萃分析。

Front Immunol. 2023 Sep 5;14:1145081. doi: 10.3389/fimmu.2023.1145081. eCollection 2023.

Antibody titer after administration of mRNA-based vaccine against severe acute respiratory syndrome coronavirus 2 in liver transplant recipients.肝移植受者接种严重急性呼吸综合征冠状病毒2 mRNA疫苗后的抗体滴度

Ann Gastroenterol Surg. 2023 Apr 19;7(5):800-807. doi: 10.1002/ags3.12677. eCollection 2023 Sep.

A prospective observational study to evaluate the safety of COVID-19 mRNA vaccines administered to Qatar Rehabilitation Institute patients.一项前瞻性观察性研究，旨在评估向卡塔尔康复研究所患者接种新冠病毒mRNA疫苗的安全性。

Qatar Med J. 2023 Mar 1;2023(1):10. doi: 10.5339/qmj.2023.10. eCollection 2023.

COVID-19 vaccination and liver disease.COVID-19 疫苗接种与肝脏疾病。

World J Gastroenterol. 2022 Dec 28;28(48):6791-6810. doi: 10.3748/wjg.v28.i48.6791.

The Trajectory of the COVID-19 Vaccine Antibody Titers Over Time and the Association of Mycophenolate Mofetil in Solid Organ Transplant Recipients.COVID-19 疫苗抗体效价随时间的变化轨迹及吗替麦考酚酯在实体器官移植受者中的作用。

Transplant Proc. 2022 Dec;54(10):2638-2645. doi: 10.1016/j.transproceed.2022.10.023. Epub 2022 Oct 7.

Humoral Immunogenicity to SARS-CoV-2 Vaccination in Liver Transplant Recipients: A Systematic Review and Meta-Analysis.肝移植受者对 SARS-CoV-2 疫苗接种的体液免疫原性：系统评价和荟萃分析。

Int J Biol Sci. 2022 Sep 21;18(15):5849-5857. doi: 10.7150/ijbs.77030. eCollection 2022.

本文引用的文献

Antibody Response to a Fourth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.实体器官移植受者第四剂 SARS-CoV-2 疫苗的抗体反应：病例系列。

Transplantation. 2021 Dec 1;105(12):e280-e281. doi: 10.1097/TP.0000000000003934.

Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients.移植受者中第三剂mRNA-1273疫苗的随机试验。

N Engl J Med. 2021 Sep 23;385(13):1244-1246. doi: 10.1056/NEJMc2111462. Epub 2021 Aug 11.

Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients.实体器官移植受者中第三剂基于抗SARS-CoV-2信使核糖核酸的疫苗加强接种的有效性

Am J Transplant. 2022 Jan;22(1):322-323. doi: 10.1111/ajt.16775. Epub 2021 Aug 31.

Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses.肾移植受者对两剂mRNA-1273 SARS-CoV-2疫苗血清学反应微弱，接种第三剂后的抗体反应

JAMA. 2021 Jul 23;326(11):1063-5. doi: 10.1001/jama.2021.12339.

Antibody response after second BNT162b2 dose in allogeneic HSCT recipients.异基因造血干细胞移植受者第二次接种BNT162b2后的抗体反应。

Lancet. 2021 Jul 24;398(10297):298-299. doi: 10.1016/S0140-6736(21)01594-4. Epub 2021 Jul 13.

Serological Response in Lung Transplant Recipients after Two Doses of SARS-CoV-2 mRNA Vaccines.两剂严重急性呼吸综合征冠状病毒2（SARS-CoV-2）信使核糖核酸（mRNA）疫苗接种后肺移植受者的血清学反应

Vaccines (Basel). 2021 Jun 30;9(7):708. doi: 10.3390/vaccines9070708.

Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.实体器官移植受者接种第三剂新冠病毒疫苗的安全性和免疫原性：病例系列

Ann Intern Med. 2021 Sep;174(9):1330-1332. doi: 10.7326/L21-0282. Epub 2021 Jun 15.

Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients.实体器官移植受者对两剂严重急性呼吸综合征冠状病毒2信使核糖核酸疫苗系列的抗体反应。

JAMA. 2021 Jun 1;325(21):2204-2206. doi: 10.1001/jama.2021.7489.

Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients.肝移植受者对 SARS-CoV-2 疫苗的免疫原性较低。

J Hepatol. 2021 Aug;75(2):435-438. doi: 10.1016/j.jhep.2021.04.020. Epub 2021 Apr 21.

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。

N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验